BioSpace News Archive

Business

BD Names Dr. Carrie Byington To Board Of Directors

BD (Becton, Dickinson and Company) today announced that Dr. Carrie L. Byington has been appointed to the company’s board of directors, bringing the total number of directors to 13.

October 22, 2021
·
3 min read
Business

ProMIS Neurosciences Appoints Accomplished Biotech Executive, Dr. Maggie Shafmaster, to its Board of Directors

ProMIS Neurosciences, Inc. today announced the appointment of Maggie Shafmaster, PhD, JD, to its Board of Directors with immediate effect.

October 22, 2021
·
4 min read
Business

ProMIS Neurosciences Announces Update to Senior Management TeamExpanded management team to lead development programs with special focus on PMN310 for Alzheimer’s disease

ProMIS Neurosciences, Inc. today announced several updates to its senior management team.

October 22, 2021
·
4 min read
Pharm Country

ADMA Biologics Announces Data Presented at the 2021 ISIRV-WHO Conference

ADMA Biologics, Inc. today announced that a poster presentation was made at the virtual 2021 International Society for Influenza and other Respiratory Virus Diseases - World Health Organization (ISIRV-WHO) Conference.

October 22, 2021
·
9 min read
Deals

Berkshire Biomedical Raises $2.75 Million in Convertible Debt

Berkshire Biomedical Corporation announced today that the company issued $2.75 million in 8% convertible promissory notes (the “Notes”) to a group of qualified investors, including founding and other investors who participated in the previous capital raise.

October 22, 2021
·
4 min read
Drug Development

Humanigen announces preparation of Phase 1b study of ifabotuzumab in solid tumors following presentation of Phase 1 study results at EANM‘21

An abstract showing tumor specific targeting at all known tumor sites in glioblastoma patients, with no normal tissue uptake of ifabotuzumab, from a Phase 1 study will be presented at EANM‘21

October 22, 2021
·
6 min read
Business

RaySearch and Mevion to Develop Next-Generation Treatment Planning Techniques for FLASH Proton Radiotherapy Treatment

RaySearch Laboratories AB (publ) and Mevion Medical Systems , two companies that are leading the field of proton therapy, announce a collaboration to develop advanced treatment planning techniques for FLASH delivery with the MEVION S250i Proton Therapy System.

October 22, 2021
·
3 min read
Drug Development

Generation Bio Presents Data Demonstrating First Lipid Nanoparticle to Achieve Uniform Retinal Transduction and Tolerability via Sub-Retinal Delivery of ceDNA and mRNA at the European Society of Gene and Cell Therapy 2021 Annual Virtual Congress

Generation Bio Co. today presented new preclinical data demonstrating widespread delivery of multiple nucleic acid cargos to photoreceptors using the company’s cell-targeted lipid nanoparticle (ctLNP).

October 22, 2021
·
5 min read
Vivos Therapeutics to Participate at the Benzinga Global Small Cap ConferenceVivos management to present at 12:15 pm Eastern Time on October 27, 2021

Vivos Therapeutics, Inc. today announced that Vivos’ Chairman and Chief Executive Officer, Kirk Huntsman, and Vivos’ Chief Financial Officer, Brad Amman, will be presenting at the online Benzinga Global Small Cap Conference at 12:15 pm ET on Wednesday, October 27, 2021.

October 22, 2021
·
4 min read
Pharm Country

Click Therapeutics Completes $52 Million Series B Financing Co-Led by H.I.G. BioHealth Partners and Accelmed Partners

Click Therapeutics, Inc. today announced that it has closed a $52 million upsized Series B financing.

October 22, 2021
·
4 min read